Publication:
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019

Thumbnail Image

Files

Interim201819InfluenzaVaccine_2019.pdf (562.72 KB)
Identifiers
URI: http://hdl.handle.net/20.500.12105/8980
ISSN: 1560-7917
DOI: 10.2807/1560-7917.ES.2019.24.1900121

Publication date

2019

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publishers

Metrics
Google Scholar
Export
MarcXML METS

Research Projects

Organizational Units

Journal Issue

Abstract

Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.

Description

Keywords

Europe Influenza Multicentre study Test-negative design Vaccination Vaccine effectiveness Vaccines and immunisation

MeSH Terms

DeCS Terms

Bibliographic citation

Euro Surveill. 2019 Feb;24(8):1900121.

Collections

Centro Nacional de Microbiología (CNM)
Centro Nacional de Epidemiología (CNE)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)

Publisher version

https://doi.org/10.2807/1560-7917.ES.2019.24.1900121

Related dataset

Related publication

Document type

research article